Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

Primordial Prevention of Cardiovascular Disease - The Role of Blood Pressure

Citation:

European Cardiovascular Disease 2007;3(2):20–1

Cerebrovascular Protection by New Antihypertensive Drugs

Citation:

European Cardiovascular Disease 2006;2(2):14–6

Bosentan in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (Congenital Cardiac Shunts)

Citation:

European Cardiovascular Disease 2007;3(1):113–4

Amlodipine in the Prevention and Treatment of Cardiovascular Disease

Citation:

European Cardiovascular Disease 2007;3(2):66–8